Lorenzo Gerratana
@gerratana.bsky.social
Physician scientist, Breast Oncology @CroAviano, @Uniud, @LiquidBioGroup, @CtcLaboratory. #TranslationalResearch, #PrecisionMedicine, Mac Geek, Ramen Addicted.
🔭 We propose a biomarker-driven clinical trial model:
• Stratify by CTC count + phenotype
• Adjust treatment intensity
• Monitor CTCs/ctDNA longitudinally
• Assess outcomes in molecular context
🧪 This approach supports personalized strategies beyond conventional clinical or imaging criteria.
• Stratify by CTC count + phenotype
• Adjust treatment intensity
• Monitor CTCs/ctDNA longitudinally
• Assess outcomes in molecular context
🧪 This approach supports personalized strategies beyond conventional clinical or imaging criteria.
April 5, 2025 at 6:51 PM
🔭 We propose a biomarker-driven clinical trial model:
• Stratify by CTC count + phenotype
• Adjust treatment intensity
• Monitor CTCs/ctDNA longitudinally
• Assess outcomes in molecular context
🧪 This approach supports personalized strategies beyond conventional clinical or imaging criteria.
• Stratify by CTC count + phenotype
• Adjust treatment intensity
• Monitor CTCs/ctDNA longitudinally
• Assess outcomes in molecular context
🧪 This approach supports personalized strategies beyond conventional clinical or imaging criteria.
❓ Why does this matter?
CTC dynamics can guide treatment intensity—e.g. STIC CTC trial—and integrate with ctDNA to refine therapeutic strategies.
#LiquidBiopsy #OncologyResearch
CTC dynamics can guide treatment intensity—e.g. STIC CTC trial—and integrate with ctDNA to refine therapeutic strategies.
#LiquidBiopsy #OncologyResearch
April 5, 2025 at 6:51 PM
❓ Why does this matter?
CTC dynamics can guide treatment intensity—e.g. STIC CTC trial—and integrate with ctDNA to refine therapeutic strategies.
#LiquidBiopsy #OncologyResearch
CTC dynamics can guide treatment intensity—e.g. STIC CTC trial—and integrate with ctDNA to refine therapeutic strategies.
#LiquidBiopsy #OncologyResearch